Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Imidazole-based protein farnesyltransferase inhibitors for cancer

June 1, 1999

More on protein farnesyltransferase inhibitors in development at Merck

June 1, 1999

Chinese scientists discover new MDR reversal agents during search for cardiovascular agents

June 1, 1999

Recombinant enzyme plus gene therapy: a unique combination therapy for cancer

May 31, 1999

CPMP recommends expanded approval of Temodal for brain tumor therapy

May 31, 1999

Ilex initiates clinical testing of vitamin D3 analogue

May 31, 1999

EntreMed announces sites for Endostatin phase I clinical trials

May 31, 1999

More news from ASCO: safety and pharmacokinetics of squalamine examined in phase I trials

May 28, 1999

Survival advantage for exemestane observed in phase III breast cancer trial reported at ASCO meeting

May 28, 1999

DNA ligase inhibitors with alpha-pyrone structure in development at Millennium

May 28, 1999

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...